Animal study · rats

BPC-157 closed duodenocolic fistulas in rats

Checked against the paper Animal studyPublished by PepVault

The takeaway

In rats, BPC-157 given by mouth in water or by injection healed a surgically made fistula between the small intestine and colon, which adds an animal gut-healing result rather than evidence in people.

Kind
Animal study
Studied in
Rats
Published
2024
Journal
J Physiol Pharmacol

What they tested

The team tested whether BPC-157 could heal a fistula, an abnormal opening joining the duodenum (the first part of the small intestine) and the colon, in rats.

How the study was done

An animal study in rats in which a duodenocolic fistula was made by joining two perforated lesions, one in the duodenum and one in the colon. Rats got BPC-157 at 10 μg/kg or 10 ng/kg, either in drinking water or by intraperitoneal injection (into the belly cavity), and were checked at day 1, 3, 7, 14, 21 and 28 against untreated controls; a separate early phase gave it at the fistula or into the stomach and watched the first 15 minutes.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

Model. Individual results vary.

PepVault for iPhone

Taking BPC-157? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

In rats, every BPC-157-treated animal closed both the duodenal and the colonic defect, with no fistula leakage, no diarrhea and no wasting, and kept its pre-surgery weight. Treated rats also had much less adhesion formation (scar tissue sticking organs together) and less blockage of intestinal passage. Control rats kept both defects open and had ongoing leakage, diarrhea, steady weight loss, heavy adhesions and intestinal obstruction. In the first minutes after BPC-157, blood vessels at both the duodenum and colon gathered toward the defect, with gene activity of NOS-2 going up and of COX-2, VEGF-A, NOS-1 and NOS-3 going down.

What it doesn’t show

This is rat work in a surgically made fistula, so it is not a human result. It tested two doses in one injury model.

The paper

Vukusic et al. Duodenocolic fistula healing by pentadecapeptide BPC 157 in rats. A cytoprotection viewpoint. J Physiol Pharmacol. 2024.

The compound

More studies on BPC-157

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking BPC-157? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo